MiNK Therapeutics, Inc. - stock earnings
INKT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -5.1 million USD | ? USD |
| 2023Q2 | -6.2 million USD | ? USD |
| 2023Q1 | 162.5 million USD | 11.7 billion USD |
| 2022Q4 | -7.5 million USD | 2.7 billion USD |
| 2022Q3 | -4.6 million USD | 1.6 billion USD |
| 2022Q2 | -4.5 million USD | 1.6 billion USD |
| 2022Q1 | -8.2 million USD | ? USD |
| 2021Q4 | -5.8 million USD | 221.9 million USD |
| 2021Q3 | -14.3 million USD | ? USD |
| 2021Q2 | -6.3 million USD | ? USD |
| 2021Q1 | -3.8 million USD | ? USD |
| 2020Q4 | -1.5 million USD | ? USD |
| 2020Q3 | -6.0 million USD | ? USD |
INKT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -24.8 million USD | ? USD |
| 2022 | -24.8 million USD | 2.7 billion USD |
| 2021 | -23.1 million USD | ? USD |
| 2020 | -15.7 million USD | ? USD |
| 2019 | -25.9 million USD | 689626 USD |
INKT
Price: $0.98
52 week price:
Earnings Per Share: -0.65 USD
P/E Ratio: -1.25
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 4128
Market Capitalization: 34.2 million